242 related articles for article (PubMed ID: 27412347)
1. Burden of asthma with elevated blood eosinophil levels.
Casciano J; Krishnan JA; Small MB; Buck PO; Gopalan G; Li C; Kemp R; Dotiwala Z
BMC Pulm Med; 2016 Jul; 16(1):100. PubMed ID: 27412347
[TBL] [Abstract][Full Text] [Related]
2. Value of peripheral blood eosinophil markers to predict severity of asthma.
Casciano J; Krishnan JA; Small MB; Buck PO; Gopalan G; Li C; Kemp R; Dotiwala Z
BMC Pulm Med; 2016 Jul; 16(1):109. PubMed ID: 27473851
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Economic Burden of Elevated Blood Eosinophils in Patients With and Without Uncontrolled Asthma.
Casciano J; Krishnan J; Dotiwala Z; Li C; Sun SX
J Manag Care Spec Pharm; 2017 Jan; 23(1):85-91. PubMed ID: 28025926
[TBL] [Abstract][Full Text] [Related]
4. Effect of clinically significant thresholds of eosinophil elevation on health care resource use in asthma.
Dotiwala Z; Casciano J; Davis JR; Fox K; Gopalan G; Rastogi S; Lamerato L; Mathur SK
Ann Allergy Asthma Immunol; 2020 Aug; 125(2):182-189. PubMed ID: 32371242
[TBL] [Abstract][Full Text] [Related]
5. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
[TBL] [Abstract][Full Text] [Related]
6. The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization.
Viinanen A; Lassenius MI; Toppila I; Karlsson A; Veijalainen L; Idänpään-Heikkilä JJ; Laitinen T
J Asthma; 2020 Oct; 57(10):1092-1102. PubMed ID: 31267775
[No Abstract] [Full Text] [Related]
7. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.
Price DB; Rigazio A; Campbell JD; Bleecker ER; Corrigan CJ; Thomas M; Wenzel SE; Wilson AM; Small MB; Gopalan G; Ashton VL; Burden A; Hillyer EV; Kerkhof M; Pavord ID
Lancet Respir Med; 2015 Nov; 3(11):849-58. PubMed ID: 26493938
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and disease burden of severe eosinophilic asthma in Japan.
Nagasaki T; Sato K; Kume N; Oguma T; Sunadome H; Ito I; Izuhara Y; Okamoto K; Kobayashi S; Ohno T; Mizukami A; Kobayashi A; Kaise T; Kuroda T; Mishima M; Matsumoto H
J Asthma; 2019 Nov; 56(11):1147-1158. PubMed ID: 30822174
[No Abstract] [Full Text] [Related]
9. Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain.
Sicras-Mainar A; Capel M; Navarro-Artieda R; Nuevo J; Orellana M; Resler G
J Med Econ; 2020 May; 23(5):492-500. PubMed ID: 31958257
[No Abstract] [Full Text] [Related]
10. Association between blood eosinophil count with asthma hospital readmissions.
Gonzalez-Barcala FJ; San-Jose ME; Nieto-Fontarigo JJ; Carreira JM; Calvo-Alvarez U; Cruz MJ; Facal D; Garcia-Sanz MT; Valdes-Cuadrado L; Salgado FJ
Eur J Intern Med; 2018 Jul; 53():34-39. PubMed ID: 29514744
[TBL] [Abstract][Full Text] [Related]
11. Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients.
Parra A; Sanz ML; Vila L; Prieto I; Diéguez I; Oehling AK
J Investig Allergol Clin Immunol; 1999; 9(1):27-34. PubMed ID: 10212854
[TBL] [Abstract][Full Text] [Related]
12. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
Katz LE; Gleich GJ; Hartley BF; Yancey SW; Ortega HG
Ann Am Thorac Soc; 2014 May; 11(4):531-6. PubMed ID: 24606022
[TBL] [Abstract][Full Text] [Related]
13. Blood eosinophil count correlates with severity of respiratory failure in life-threatening asthma and predicts risk of subsequent exacerbations.
Yii ACA; Tay TR; Puah SH; Lim HF; Li A; Lau P; Tan R; Neo LP; Chung KF; Koh MS
Clin Exp Allergy; 2019 Dec; 49(12):1578-1586. PubMed ID: 31310686
[TBL] [Abstract][Full Text] [Related]
14. Serum eosinophil peroxidase (EPO) levels in asthmatic patients.
Sanz ML; Parra A; Prieto I; Diéguez I; Oehling AK
Allergy; 1997 Apr; 52(4):417-22. PubMed ID: 9188923
[TBL] [Abstract][Full Text] [Related]
15. Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study.
Kerkhof M; Tran TN; van den Berge M; Brusselle GG; Gopalan G; Jones RCM; Kocks JWH; Menzies-Gow A; Nuevo J; Pavord ID; Rastogi S; Price DB
PLoS One; 2018; 13(7):e0201143. PubMed ID: 30044863
[TBL] [Abstract][Full Text] [Related]
16. Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.
Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
J Allergy Clin Immunol Pract; 2017; 5(4):1050-1060.e9. PubMed ID: 28215604
[TBL] [Abstract][Full Text] [Related]
17. Incremental direct expenditure of treating asthma in the United States.
Kamble S; Bharmal M
J Asthma; 2009 Feb; 46(1):73-80. PubMed ID: 19191142
[TBL] [Abstract][Full Text] [Related]
18. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis.
Jacob C; Bechtel B; Engel S; Kardos P; Linder R; Braun S; Greiner W
Eur J Health Econ; 2016 Mar; 17(2):195-201. PubMed ID: 25716136
[TBL] [Abstract][Full Text] [Related]
19. Variability of blood eosinophils in patients in a clinic for severe asthma.
Rakowski E; Zhao S; Liu M; Ahuja S; Durmus N; Grunig G; Curotto de Lafaille M; Wu Y; Reibman J
Clin Exp Allergy; 2019 Feb; 49(2):163-170. PubMed ID: 30415509
[TBL] [Abstract][Full Text] [Related]
20. Progression to Uncontrolled Severe Asthma: A Novel Risk Equation.
Casciano J; Krishnan J; Small MB; Li C; Dotiwala Z; Martin BC
J Manag Care Spec Pharm; 2017 Jan; 23(1):44-50. PubMed ID: 28025923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
